|
Volumn 295, Issue 3, 2000, Pages 1005-1011
|
Antidiuretic effects of a nonpeptide vasopressin V2-receptor agonist, OPC-51803, administered orally to rats
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [1 (2 CHLORO 4 (1 PYRROLIDINYL)BENZOYL) 2,3,4,5 TETRAHYDRO 1H BENZAZEPIN 5 YL] N ISOPROPYLACETAMIDE;
OPC 51803;
UNCLASSIFIED DRUG;
VASOPRESSIN RECEPTOR ANTAGONIST;
VASOPRESSIN V2 RECEPTOR;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DIABETES INSIPIDUS;
DIURESIS;
DOSE RESPONSE;
DRUG EFFECT;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
FEMALE;
HORMONE BLOOD LEVEL;
KIDNEY;
LIVER;
MALE;
NOCTURIA;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RECEPTOR AFFINITY;
URINE INCONTINENCE;
URINE OSMOLALITY;
ADMINISTRATION, ORAL;
ANIMALS;
ARGININE VASOPRESSIN;
BENZAZEPINES;
BLOOD PRESSURE;
CREATININE;
DIABETES INSIPIDUS;
DIURESIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
KIDNEY;
LIVER;
MALE;
PYRROLIDINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, VASOPRESSIN;
|
EID: 0033712423
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (20)
|
References (29)
|